| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.689 | 0.005 | 0.738 | Anticonvulsant | 0.738 0.005 DBMET03182 | DBMET03182 | |
| 0.661 | 0.002 | 0.661 | Benzodiazepine agonist | 0.326 0.003 DBMET03182 | ||
| 0.63 | 0.004 | 0.63 | Anesthetic general | 0.61 0.004 DBMET03182 | ||
| 0.563 | 0.004 | 0.568 | Platelet adhesion inhibitor | 0.568 0.004 DBMET03182 | DBMET03182 | |
| 0.505 | 0.003 | 0.505 | GABA receptor antagonist | 0.429 0.004 DBMET03182 | ||
| 0.487 | 0.003 | 0.487 | GABA A receptor antagonist | 0.381 0.004 DBMET03182 | ||
| 0.436 | 0.015 | 0.436 | Platelet aggregation inhibitor | 0.43 0.015 DBMET03182 | ||
| 0.419 | 0.105 | 0.419 | Apoptosis agonist | 0.38 0.124 DBMET03182 | ||
| 0.301 | 0.006 | 0.301 | GABA receptor agonist | 0.298 0.006 DBMET03182 | ||
| 0.285 | 0.002 | 0.285 | Benzodiazepine antagonist | 0.101 0.004 DBMET03182 | ||
| 0.399 | 0.14 | 0.422 | Antiinflammatory | 0.422 0.126 DBMET03182 | DBMET03182 | |
| 0.258 | 0.005 | 0.258 | GABA A receptor agonist | 0.177 0.012 DBMET03182 | ||
| 0.27 | 0.029 | 0.334 | Thrombolytic | 0.334 0.019 DBMET03182 | DBMET03182 | |
| 0.222 | 0.005 | 0.237 | I kappa B kinase 1 inhibitor | 0.237 0.005 DBMET03182 | DBMET03182 | |
| 0.274 | 0.062 | 0.326 | Platelet antagonist | 0.326 0.044 DBMET03182 | DBMET03182 | |
| 0.27 | 0.096 | 0.27 | Caspase 3 stimulant | 0.261 0.103 DBMET03182 | ||
| 0.171 | 0.005 | 0.171 | Bromodomain-containing protein 4 inhibitor | 0.158 0.005 DBMET03182 | ||
| 0.262 | 0.116 | 0.293 | Apoptosis antagonist | 0.293 0.09 DBMET03182 | DBMET03182 | |
| 0.14 | 0.003 | 0.14 | Benzodiazepine receptor peripheral-type antagonist | 0.11 0.003 DBMET03182 | ||
| 0.243 | 0.113 | 0.253 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.253 0.104 DBMET03182 | DBMET03182 | |
| 0.202 | 0.107 | 0.202 | Tumour necrosis factor alpha release inhibitor | |||
| 0.089 | 0.007 | 0.089 | Bromodomain-containing protein 3 inhibitor | 0.085 0.007 DBMET03182 | ||
| 0.186 | 0.121 | 0.186 | RNA-directed DNA polymerase inhibitor | |||
| 0.137 | 0.077 | 0.137 | Protein kinase C nu inhibitor | 0.121 0.091 DBMET03182 | ||
| 0.192 | 0.146 | 0.198 | MAP kinase kinase 3 inhibitor | 0.198 0.127 DBMET03182 | DBMET03182 | |
| 0.092 | 0.047 | 0.119 | Hematopoietic | 0.119 0.023 DBMET03182 | DBMET03182 | |
| 0.202 | 0.16 | 0.204 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.204 0.155 DBMET03182 | DBMET03182 | |
| 0.061 | 0.019 | 0.065 | Farnesyltransferase inhibitor | 0.065 0.018 DBMET03182 | DBMET03182 | |
| 0.269 | 0.23 | 0.269 | Caspase 9 stimulant | 0.257 0.245 DBMET03182 | ||
| 0.041 | 0.009 | 0.042 | Liver X receptor alpha antagonist | 0.042 0.008 DBMET03182 | DBMET03182 | |
| 0.066 | 0.037 | 0.092 | Prostaglandin F2 alpha antagonist | 0.092 0.015 DBMET03182 | DBMET03182 | |
| 0.104 | 0.077 | 0.104 | Acetylcholine release stimulant | |||
| 0.041 | 0.013 | 0.043 | Liver X receptor antagonist | 0.043 0.012 DBMET03182 | DBMET03182 | |
| 0.046 | 0.027 | 0.071 | Cholecystokinin antagonist | 0.071 0.014 DBMET03182 | DBMET03182 | |
| 0.119 | 0.113 | 0.143 | Anticoagulant | 0.143 0.087 DBMET03182 | DBMET03182 | |
| 0.092 | 0.089 | 0.114 | Chelator | 0.114 0.06 DBMET03182 | DBMET03182 | |
| 0.202 | 0.199 | 0.25 | Toll-Like receptor agonist | 0.25 0.148 DBMET03182 | DBMET03182 | |
| 0.085 | 0.104 | 0.106 | Folate antagonist | 0.106 0.055 DBMET03182 | DBMET03182 | |
| 0.189 | 0.216 | 0.245 | Toll-Like receptor 7 agonist | 0.245 0.152 DBMET03182 | DBMET03182 | |
| 0.081 | 0.114 | 0.115 | Nav1.4 sodium channel blocker | 0.115 0.057 DBMET03182 | DBMET03182 | |
| 0.03 | 0.067 | 0.085 | AMPA receptor antagonist | 0.085 0.015 DBMET03182 | DBMET03182 | |
| 0.031 | 0.075 | 0.039 | GABA B receptor antagonist | 0.039 0.038 DBMET03182 | DBMET03182 | |
| 0.012 | 0.063 | 0.03 | AMPA 2 receptor antagonist | 0.03 0.02 DBMET03182 | DBMET03182 | |
| 0.164 | 0.223 | 0.221 | Insulysin inhibitor | 0.221 0.127 DBMET03182 | DBMET03182 | |
| 0.098 | 0.162 | 0.182 | Insulin secretagoues | 0.182 0.047 DBMET03182 | DBMET03182 | |
| 0.107 | 0.175 | 0.136 | Interleukin antagonist | 0.136 0.129 DBMET03182 | DBMET03182 | |
| 0.015 | 0.103 | 0.038 | Urate transporter 1 inhibitor | 0.038 0.028 DBMET03182 | DBMET03182 | |
| 0.036 | 0.125 | 0.205 | Porphobilinogen synthase inhibitor | 0.205 0.012 DBMET03182 | DBMET03182 | |
| 0.009 | 0.099 | 0.046 | AMPA 3 receptor antagonist | 0.046 0.011 DBMET03182 | DBMET03182 | |
| 0.021 | 0.121 | 0.055 | Prostaglandin EP2 antagonist | 0.055 0.046 DBMET03182 | DBMET03182 | |
| 0.184 | 0.299 | 0.323 | Cyclophilin D inhibitor | 0.323 0.143 DBMET03182 | DBMET03182 | |
| 0.015 | 0.214 | 0.037 | AMPA 4 receptor antagonist | 0.037 0.032 DBMET03182 | DBMET03182 | |
| 0.018 | 0.267 | 0.074 | Phenylalanine 4-hydroxylase inhibitor | 0.074 0.043 DBMET03182 | DBMET03182 | |
| 0.109 | 0.363 | 0.231 | Sodium/bile acid cotransporter inhibitor | 0.231 0.149 DBMET03182 | DBMET03182 | |
| 0.094 | 0.511 | 0.21 | Interleukin 2 agonist | 0.21 0.173 DBMET03182 | DBMET03182 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |